As of 2025-09-16, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 18.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.47 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is 6.4%.
The range of the Relative Valuation is (7.83) - 48.73 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 14.6x | 13.6x |
| Forward P/E multiples | 13.2x - 14.5x | 13.5x |
| Fair Price | (7.83) - 48.73 | 18.59 |
| Upside | -144.8% - 179.0% | 6.4% |
| Date | P/E |
| 2025-09-15 | -29.45 |
| 2025-09-12 | -29.32 |
| 2025-09-11 | -30.20 |
| 2025-09-10 | -29.03 |
| 2025-09-09 | -29.74 |
| 2025-09-08 | -29.67 |
| 2025-09-05 | -31.54 |
| 2025-09-04 | -31.12 |
| 2025-09-03 | -31.95 |
| 2025-09-02 | -30.62 |
| 2025-08-29 | -30.68 |
| 2025-08-28 | -30.92 |
| 2025-08-27 | -30.46 |
| 2025-08-26 | -30.79 |
| 2025-08-25 | -30.45 |
| 2025-08-22 | -34.09 |
| 2025-08-21 | -33.82 |
| 2025-08-20 | -34.70 |
| 2025-08-19 | -34.02 |
| 2025-08-18 | -35.39 |
| 2025-08-15 | -36.77 |
| 2025-08-14 | -34.22 |
| 2025-08-13 | -34.39 |
| 2025-08-12 | -31.70 |
| 2025-08-11 | -30.25 |
| 2025-08-08 | -30.73 |
| 2025-08-07 | -30.28 |
| 2025-08-06 | -27.41 |
| 2025-08-05 | -28.24 |
| 2025-08-04 | -28.83 |
| 2025-08-01 | -26.82 |
| 2025-07-31 | -27.68 |
| 2025-07-30 | -28.24 |
| 2025-07-29 | -26.69 |
| 2025-07-28 | -23.37 |
| 2025-07-25 | -20.11 |
| 2025-07-24 | -21.71 |
| 2025-07-23 | -22.46 |
| 2025-07-22 | -22.95 |
| 2025-07-21 | -22.46 |
| 2025-07-18 | -23.73 |
| 2025-07-17 | -37.04 |
| 2025-07-16 | -30.99 |
| 2025-07-15 | -30.70 |
| 2025-07-14 | -32.42 |
| 2025-07-11 | -30.63 |
| 2025-07-10 | -32.14 |
| 2025-07-09 | -32.66 |
| 2025-07-08 | -32.08 |
| 2025-07-07 | -29.20 |